Morbidity and Mortality Associated with Development of Hypogammaglobulinemia after Rituximab
Year: 2019
Type: article
Study design: Observational Study
Abstract: Congratulations for the upcoming issue of Internal Medicine – Open Journal (IMOJ). I feel glad to observe the development of new world with many historical antecedent doctors. At first, I would like to introduce a prominent doctor, Shigeaki Hinohara, who has been well-known worldwide.1 He had been extremely active in various fields until 105 years as a physician in the St. Luke International Hospital, Tokyo, Japan.
Source: Internal Medicine - Open Journal
DOI: 10.17140/imoj-3-110
Institutions: Kindai University Nara Hospital, Kindai University
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Keywords: hypogammaglobulinemia, rituximab, morbidity, mortality
Open Access status: diamond
OpenAlex ID: W3000499243
